These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 6803719)
1. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination]. Starkman C; Estampes B; Vernant P; Acar J Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719 [No Abstract] [Full Text] [Related]
2. [Prevention of arterial embolisms by the combination of dipyridamole and antivitamins K in patients with artificial valves. Apropos of a series of 314 operated valves]. Cribier A; Sibille C; Brunhes G; Richard C; Soyer R; Letac B Arch Mal Coeur Vaiss; 1982 Jan; 75(1):89-98. PubMed ID: 6803720 [No Abstract] [Full Text] [Related]
3. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. Sullivan JM; Harken DE; Gorlin R N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099 [No Abstract] [Full Text] [Related]
4. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. Sullivan JM; Harken DE; Gorlin R N Engl J Med; 1968 Sep; 279(11):576-80. PubMed ID: 5667468 [No Abstract] [Full Text] [Related]
5. Use of Persantine in preventing thromboembolism following valve replacement. Arrants JE; Hairston P Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046 [No Abstract] [Full Text] [Related]
6. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis. Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773 [TBL] [Abstract][Full Text] [Related]
7. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407 [TBL] [Abstract][Full Text] [Related]
8. A practical approach for bridging anticoagulation after mechanical heart valve replacement. Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932 [TBL] [Abstract][Full Text] [Related]
9. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve. Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143 [No Abstract] [Full Text] [Related]
10. Prevention of thromboembolic complications of valve prostheses by agents affecting platelet function. Wyss M; Diez C; Balavoine JF; Martin D; Bouvier CA Eur J Cardiol; 1978 Oct; 8(3):337-47. PubMed ID: 710491 [No Abstract] [Full Text] [Related]
11. [Anti-thromboembolic therapy and effects of dipyridamole on platelet function in patients with heart valve prostheses (authors transl)]. Tokumo M; Doko S; Ono Y; Takabatake T; Noguchi A; Omoto T; Teramoto S Kyobu Geka; 1978; 31(1):19-22. PubMed ID: 628105 [No Abstract] [Full Text] [Related]
12. Do all patients with mechanical heart valve prostheses need anticoagulant therapy? Dale J; Nitter-Hauge S Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714 [No Abstract] [Full Text] [Related]
13. [Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications]. Delahaye JP; Milon H; Ffrench P; Philippe-Bert J; Malquarti V; Saradarian W Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):205-11. PubMed ID: 3893303 [TBL] [Abstract][Full Text] [Related]
14. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246 [TBL] [Abstract][Full Text] [Related]
15. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement]. Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466 [TBL] [Abstract][Full Text] [Related]
16. [Beall prosthesis. Its use in the surgical treatment of mitral valve diseases]. Goudard A; Monties JR; Baille Y; Jausseran JM; Sicard MP; Avierinos C; Henry E Nouv Presse Med; 1972 Apr; 1(16):1069-72. PubMed ID: 5035862 [No Abstract] [Full Text] [Related]
17. [A study on anticoagulations and thromboembolic complication in aortic and double valve replacement with Starr-Edwards ball valve prostheses (author's transl)]. Sakashita I; Nakamura C; Ohtani S; Asano K Nihon Kyobu Geka Gakkai Zasshi; 1977 Nov; 25(11):1470-5. PubMed ID: 609012 [No Abstract] [Full Text] [Related]
18. [Drug-induced modification of thrombocyte turnover in patients with artificial heart valves]. Kummer H; Hunziker HR; Althaus U Schweiz Med Wochenschr; 1974 Jan; 104(4):142-4. PubMed ID: 4811472 [No Abstract] [Full Text] [Related]
19. Optimal target international normalized ratio for patients with mechanical heart valves. Takkenberg JJ; Puvimanasinghe JP; van Herwerden LA J Am Coll Cardiol; 2004 Sep; 44(5):1142-3; author reply 1144-5. PubMed ID: 15337235 [No Abstract] [Full Text] [Related]
20. [Results of valve replacement with cloth-covered Starr-Edwards ball valve prosthesis (author's transl)]. Valty J; Sagnes JY; Rozensztajn L; Gaudeul P; Bickert P; Motebassem R; Dumoulin P; Maurice P Ann Med Interne (Paris); 1980; 131(2):99-102. PubMed ID: 7396329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]